📹 2020's Silver Lining

As Wealthy Retirement's resident biotech expert, Marc Lichtenfeld is often asked what he looks for when choosing biotech stocks. Here's what he looks for. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

SPONSORED 417-3! Congress Passes Law That Could Reduce 401(k)s. Click Here for Details. MARKET TRENDS How to Choose High-Quality Biotech Stocks Rachel Gearhart, Associate Franchise Publisher, The Oxford Club Despite continuing market volatility, the S&P 500 has remained relatively flat in 2020 - down just 1.66%. But there is a silver lining... The biotech sector is up more than 18% since the start of the year. Many of you know Marc Lichtenfeld as the "income guy" because of his work with The Oxford Income Letter... But he's as passionate about biotech investing as he is about dividends. In fact, he's been tracking the sector for several decades now and has spoken about biotech opportunities at events all over the world. SPONSORED The World Cannot Survive... Without This Technology The market's been through hell and back... But these three tech companies are thriving and could set investors up for life. [Click Here to Get More Details on These Three Stocks] Last year, Marc hosted a summit with former Speaker of the House Newt Gingrich to uncover the opportunities within the gene therapy subsector of biotech. Since then, gene therapy companies are up nearly 40%. (Compare that with the measly returns of the S&P!) It's clear that Marc has a knack for finding biotech stocks that are poised to take off - just ask his subscribers who landed 2,381% gains on his recent recommendation! So, in Marc's latest State of the Market video, he addresses a common question from readers... "What do you look for when you invest in biotech companies?" In the short video, Marc outlines the five specific qualifications he looks for before recommending a biotech company. Click here to watch it now. Then, check out his latest research on a unique catalyst that Wall Street has been using for 28 years to land major profits within the biotech sector. We all know it pays to follow the smart money... And - if history is any indicator - it also pays to follow Marc's recommendations. Click here to watch Marc's video presentation on this unique biotech catalyst. (SPOILER: It's not clinical trials or earnings reports.) >Here are the details.< Good investing, Rachel Leave a Comment MORE FROM WEALTHY RETIREMENT Three Charts That Will Change Your Mind About This Sector How to Profit From Wall Street's Top Catalysts Are These All-American Dividends Safe? Facebook Twitter Email Share SPONSORED Top Three Coronavirus Stocks to Buy Now The panic-driven selling on Wall Street has created the ultimate buying opportunity. Get details on the three best coronavirus stocks to buy right here. You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our FAQs. Trying to reach us? Contact us here. Please do not reply to this email as it goes to an unmonitored inbox. Privacy Policy | Whitelist Wealthy Retirement | Unsubscribe © 2020 The Oxford Club, LLC All Rights Reserved The Oxford Club | 105 West Monument Street | Baltimore, MD 21201 North America: 1.800.589.3430 | International: +1.443.353.4334 | Fax: 1.410.329.1923 Oxfordclub.com The Oxford Club is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. Members should be aware that although our track record is highly rated by an independent analysis and has been legally reviewed, investment markets have inherent risks and there can be no guarantee of future profits. The stated returns may also include option trades. We expressly forbid our writers from having a financial interest in their own securities recommendations to readers. All of our employees and agents must wait 24 hours after online publication or 72 hours after the mailing of printed-only publications prior to following an initial recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, 105 W. Monument Street, Baltimore MD 21201.